Filing Details

Accession Number:
0000950170-25-034076
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-05 20:30:37
Reporting Period:
2025-03-03
Filing Date:
2025-03-05
Accepted Time:
2025-03-05 20:30:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1020214 Cerus Corp CERS Surgical & Medical Instruments & Apparatus (3841) 680262011
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1605456 K Vivek Jayaraman C/O Cerus Corporation
1220 Concord Ave Suite 600
Concord CA 94520
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-03 23,850 $0.00 916,608 No 4 M Direct
Common Stock Disposition 2025-03-04 10,780 $1.55 905,828 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2025-03-03 23,850 $0.00 23,850 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Cerus Common Stock.
  2. Includes 6,405 and 7,700 shares purchased under Issuer's Employee Stock Purchase Plan on 08/30/24 and 02/28/25.
  3. Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
  4. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.49 to $1.59 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
  5. Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer.
  6. Not applicable.